Targeted Therapies in Adult B-Cell Malignancies

por Rossi, Jean-François
Publicado 2015

Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells

por Rossi, Jean-François, Céballos, Patrice, Lu, Zhao-Yang
Publicado 2019

Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer

por Rossi, Jean-François, Lu, Zhao Yang, Massart, Cesare, Levon, Kalle
Publicado 2021

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma

por Kassambara, Alboukadel, Hose, Dirk, Moreaux, Jérôme, Rème, Thierry, Torrent, Jennifer, Rossi, Jean François, Goldschmidt, Hartmut, Klein, Bernard
Publicado 2012

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

por Mahtouk, Karène, Moreaux, Jérôme, Hose, Dirk, Rème, Thierry, Meißner, Tobias, Jourdan, Michel, Rossi, Jean François, Pals, Steven T, Goldschmidt, Hartmut, Klein, Bernard
Publicado 2010

Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model t...

por Rossi, Jean-Francois, Chiang, Hao-Chun, Lu, Zhao-Yang, Levon, Kalle, van Rhee, Frits, Kanhai, Karan, Fajgenbaum, David C, Klein, Bernard
Publicado 2021

Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling

por Rossi, Jean-François, Chiang, Hao-Chun, Lu, Zhao-Yang, Levon, Kalle, van Rhee, Frits, Kanhai, Karan, Fajgenbaum, David C., Klein, Bernard
Publicado 2022

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

por Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
Publicado 2012

Differential effects of lenalidomide during plasma cell differentiation

por Jourdan, Michel, Cren, Maïlys, Schafer, Peter, Robert, Nicolas, Duperray, Christophe, Vincent, Laure, Ceballos, Patrice, Cartron, Guillaume, Rossi, Jean-François, Moreaux, Jérôme, Chopra, Rajesh, Klein, Bernard
Publicado 2016

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism

por Allende-Vega, Nerea, Krzywinska, Ewelina, Orecchioni, Stefania, Lopez-Royuela, Nuria, Reggiani, Francesca, Talarico, Giovanna, Rossi, Jean-François, Rossignol, Rodrigue, Hicheri, Yosr, Cartron, Guillaume, Bertolini, Francesco, Villalba, Martin
Publicado 2015

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers

por Krzywinska, Ewelina, Allende-Vega, Nerea, Cornillon, Amelie, Vo, Dang-Nghiem, Cayrefourcq, Laure, Panabieres, Catherine, Vilches, Carlos, Déchanet-Merville, Julie, Hicheri, Yosr, Rossi, Jean-François, Cartron, Guillaume, Villalba, Martin
Publicado 2015

BNT162b2 mRNA COVID-19 Vaccination (BNTCV) in Patients (Pts) Having Hematological Malignancies (HM): Early tolerance with telemedicine application connecting and antibody anti-Spik...

por Rossi, Jean-Francois, Bonnet, Emmanuel, Velensek, Marion, Wisniewski, Emma, Heraud, Sophie, Boustany, Rania, David, Celeste, Dinet, Jerome, Sicard, Roland, Daures, Jean Pierre, Bonifacy, Marion, Mousset, Lysiane, Goffard, Emmanuel
Publicado 2021

The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

por Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Lyudmila Yu, Kvasova, Elena I, Harrison, Francisco, Karpova, Yulia S, Tikhonov, Anton, Khomyakova, Nadezhda F, Hardman, Tim, Rossi, Jean-François
Publicado 2021

Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study

por Rossi, Jean-François, Bonnet, Emmanuel, Castelli, Christel, Velensek, Marion, Wisniewski, Emma, Heraud, Sophie, Boustany, Rania, David, Céleste, Dinet, Jérôme, Sicard, Roland, Daures, Jean-Pierre, Bonifacy, Marion, Mousset, Lysiane, Goffart, Emmanuel
Publicado 2023

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab

por van Rhee, Frits, Rossi, Jean‐François, Simpson, David, Fosså, Alexander, Dispenzieri, Angela, Kuruvilla, John, Goh, Yeow Tee, Cho, Seok‐Goo, Capra, Marcelo, Liu, Ting, Casper, Corey, Cavet, James, Wong, Raymond S.
Publicado 2020

REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).

por Rossi, Jean-François, Bonnet, Emmanuel, Velensek, Marion, Wisniewski, Emma, Heraud, Sophie, Boustany, Rania, David, Céleste, Dinet, Jérôme, Sicard, Roland, Daures, Jean-Pierre, Bonifacy, Marion, Mousset, Lysiane, Castelli, Christel, Goffart, Emmanuel
Publicado 2022

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity

por Krzywinska, Ewelina, Cornillon, Amelie, Allende-Vega, Nerea, Vo, Dang-Nghiem, Rene, Celine, Lu, Zhao-Yang, Pasero, Christine, Olive, Daniel, Fegueux, Nathalie, Ceballos, Patrick, Hicheri, Yosr, Sobecki, Michal, Rossi, Jean-François, Cartron, Guillaume, Villalba, Martin
Publicado 2016

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

por Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Luydmila Yu, Kuntsevich, Elena V, Troshina, Anastasia A, Kvasova, Elena I, Tikhonov, Anton A, Khomyakova, Nadezhda F, Harrison, Francisco, Rossi, Jean-François, Hardman, Timothy C
Publicado 2022

Polyoxidonium(®) Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer

por Alexia, Catherine, Cren, Mailys, Louis-Plence, Pascale, Vo, Dang-Nghiem, El Ahmadi, Yasamine, Dufourcq-Lopez, Emilie, Lu, Zhao-Yang, Hernandez, Javier, Shamilov, Farkhad, Chernysheva, Olga, Vasilieva, M., Vorotnikov, I., Vishnevskay, Yana, Tupitsyn, Nikolay, Rossi, Jean-François, Villalba, Martin
Publicado 2019